![Richard Koehn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Richard Koehn
Oprichter bij SentrX Animal Care, Inc.
Profiel
Richard K.
Koehn was the founder of Carbylan Therapeutics, Inc. (founded in 2005) and SentrX Animal Care, Inc. (founded in 2006) where he holds the titles of Director and Chairman respectively.
He also held the position of Chief Executive Officer at Salus Therapeutics, Inc. and Vice President-Research at the University of Utah from 1992 to 2000.
Actieve functies van Richard Koehn
Bedrijven | Functie | Begin |
---|---|---|
SentrX Animal Care, Inc.
![]() SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Oprichter | 15-02-2010 |
Eerdere bekende functies van Richard Koehn
Bedrijven | Functie | Einde |
---|---|---|
University of Utah | Hoofd Techniek/Wetenschap/O&O | 01-01-2000 |
Carbylan Therapeutics, Inc.
![]() Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Oprichter | - |
Salus Therapeutics, Inc.
![]() Salus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Salus Therapeutics, Inc. discovers and develops RNA pharmaceutical products. It engages in the identification of drugs based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). Its drugs include antisense, small interfering RNAs, and delivery systems for DNA/RNA-based drugs. The company was founded by Dinesh C. Patel and is headquartered in Salt Lake City, UT. | Algemeen Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
SentrX Animal Care, Inc.
![]() SentrX Animal Care, Inc. Pharmaceuticals: MajorHealth Technology SentrX Animal Care, Inc. provides veterinary care services for animals. Its products include gels, film and field treatment kits, film-on-gauzes, adhesion prevention films, spray bottles, and corneal repair gel drops. The company’s products are used for horses, cats and dogs. The company was founded by Richard K. Koehn and Glenn D. Prestwich in 2006 and is headquartered in Salt Lake City, UT. | Health Technology |
Salus Therapeutics, Inc.
![]() Salus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Salus Therapeutics, Inc. discovers and develops RNA pharmaceutical products. It engages in the identification of drugs based on deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). Its drugs include antisense, small interfering RNAs, and delivery systems for DNA/RNA-based drugs. The company was founded by Dinesh C. Patel and is headquartered in Salt Lake City, UT. | Health Technology |
Carbylan Therapeutics, Inc.
![]() Carbylan Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Carbylan Therapeutics, Inc. engages in the development and market of medical devices and drug combination products to treat the pain associated with osteoarthritis. It offers Hydros Joint Therapy and Hydros-TA Joint Therapy, viscoelastic hyaluronan-based products designed to provide long term relief of the pain associated with osteoarthritis using a single intra-articular injection. The company was founded by Richard R. Orlandi, Albert Park, Glenn D. Prestwich and Richard K. Koehn in March 2004 and is headquartered in Palo Alto, CA. | Health Technology |